Legal & General Group Plc increased its stake in shares of Cabot Corp (NYSE:CBT) by 9.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 81,976 shares of the specialty chemicals company’s stock after buying an additional 6,848 shares during the period. Legal & General Group Plc owned 0.13% of Cabot worth $4,575,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. TD Asset Management Inc. lifted its position in Cabot by 120.4% during the 3rd quarter. TD Asset Management Inc. now owns 11,900 shares of the specialty chemicals company’s stock valued at $664,000 after purchasing an additional 6,500 shares during the period. Gratus Capital LLC lifted its position in Cabot by 9.9% during the 3rd quarter. Gratus Capital LLC now owns 8,853 shares of the specialty chemicals company’s stock valued at $494,000 after purchasing an additional 800 shares during the period. Fuller & Thaler Asset Management Inc. lifted its position in Cabot by 9.4% during the 3rd quarter. Fuller & Thaler Asset Management Inc. now owns 1,780,692 shares of the specialty chemicals company’s stock valued at $99,363,000 after purchasing an additional 152,988 shares during the period. Pacer Advisors Inc. lifted its position in Cabot by 11.5% during the 3rd quarter. Pacer Advisors Inc. now owns 9,232 shares of the specialty chemicals company’s stock valued at $515,000 after purchasing an additional 950 shares during the period. Finally, Dynamic Technology Lab Private Ltd acquired a new position in Cabot during the 3rd quarter valued at about $272,000. Institutional investors and hedge funds own 84.83% of the company’s stock.

Shares of Cabot Corp (CBT) opened at $61.27 on Wednesday. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.70 and a quick ratio of 1.17. The company has a market capitalization of $3,615.38, a PE ratio of 17.01, a PEG ratio of 1.55 and a beta of 1.11. Cabot Corp has a 52 week low of $50.21 and a 52 week high of $64.66.

Cabot (NYSE:CBT) last announced its quarterly earnings results on Tuesday, October 31st. The specialty chemicals company reported $0.91 EPS for the quarter, missing analysts’ consensus estimates of $0.93 by ($0.02). The company had revenue of $723.00 million during the quarter, compared to the consensus estimate of $683.30 million. Cabot had a net margin of 8.87% and a return on equity of 15.11%. The business’s revenue was up 16.8% compared to the same quarter last year. During the same period last year, the company earned $1.00 earnings per share. sell-side analysts predict that Cabot Corp will post 3.77 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Friday, December 8th. Stockholders of record on Friday, November 24th were paid a $0.315 dividend. The ex-dividend date of this dividend was Wednesday, November 22nd. This represents a $1.26 dividend on an annualized basis and a dividend yield of 2.06%. Cabot’s dividend payout ratio (DPR) is presently 33.07%.

CBT has been the topic of a number of research reports. Jefferies Group restated a “buy” rating and set a $74.00 target price on shares of Cabot in a research report on Friday, November 3rd. SunTrust Banks upgraded shares of Cabot from a “hold” rating to a “buy” rating in a research report on Tuesday. Zacks Investment Research downgraded shares of Cabot from a “buy” rating to a “hold” rating in a research report on Tuesday, November 7th. KeyCorp restated a “hold” rating on shares of Cabot in a research report on Wednesday, November 1st. Finally, Loop Capital initiated coverage on shares of Cabot in a research report on Thursday, September 28th. They set a “hold” rating and a $59.00 target price on the stock. Six equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average target price of $61.14.

TRADEMARK VIOLATION NOTICE: This news story was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another site, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be accessed at https://www.thecerbatgem.com/2017/12/20/legal-general-group-plc-raises-position-in-cabot-corp-cbt.html.

Cabot Profile

Cabot Corporation is a global specialty chemicals and performance materials company. The Company operates through four business segments: reinforcement materials, performance chemicals, purification solutions and specialty fluids. Reinforcement materials’ rubber grade carbon blacks are used to enhance the physical properties of the systems and applications in which they are incorporated.

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.